Advancing Next-Generation RNA Design Technologies

On June 18, the Mogam Institute for Biomedical Research announced that it had signed a joint research and development agreement with ST Pharm to develop RNA design and optimization technologies using artificial intelligence (AI).


Mogam Institute for Biomedical Research and ST Pharm Sign Joint Research Agreement on AI-Based RNA Design and Optimization Technologies View original image

This agreement aims to enhance competitiveness in next-generation RNA therapeutics by combining the AI-based RNA structural design capabilities of the Mogam Institute with ST Pharm's expertise in RNA drug development and manufacturing. Through this collaboration, the two organizations intend to expand the industrial applicability of AI-powered RNA design and optimization technologies while advancing a data-driven research and development framework to improve both productivity and efficiency in RNA drug development.


This partnership is especially significant as it marks the Mogam Institute's accumulated AI drug discovery expertise being leveraged through collaboration with a major partner in the domestic RNA pharmaceutical industry. The Mogam Institute currently leads research on AI drug discovery platforms based on generative AI and bio-foundation models. Through this partnership with ST Pharm, which possesses RNA platform technology, the practical and industrial potential of AI technology is expected to become even more concrete.



Hyunjin Shin, Director of the Mogam Institute, stated, "The Mogam Institute for Biomedical Research is conducting research on RNA design and optimization technologies using generative AI and bio-foundation models. This joint research is a meaningful case in that it verifies the applicability of AI technology in real industrial environments. We expect that it will enhance the efficiency of RNA drug research and development, contribute to the creation of an innovative ecosystem in Korea's bioindustry, and strengthen global competitiveness."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing